Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06576102
What this trial is testing

Evaluation of Prevalence and Risk Factors of Persistent COVID-19 in Immunocompromised Patients

Who this might be right for
Persistent COVID-19B Cell Malignancies
Maddalena Giannella 204
Testing effectiveness (Phase 2)UnknownNCT00750126
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Solid TumorsHematologic Neoplasms
University Hospital, Clermont-Ferrand 30
Early research (Phase 1)Study completedNCT00692926
What this trial is testing

Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells

Who this might be right for
MDSAnemia, AplasticInborn Errors of Metabolism+2 more
Joanne Kurtzberg, MD 37
Not applicableNot Yet RecruitingNCT07551817
What this trial is testing

The Effect of Art-Based Intervention on Fatigue, Anxiety, Perception of Nurse Presence, and Quality of Life in Patients With Hematological Cancers

Who this might be right for
Art-based InterventionHematological CancerNurse Presence+3 more
Gazi University 52
Not applicableStudy completedNCT04745416
What this trial is testing

Clinical Characteristics of Patients With Leukemia and COVID-19

Who this might be right for
Leukemia, AcuteCovid19Leukemia, Lymphoblastic
Hospital General de Mexico 30
Not applicableLooking for participantsNCT04841447
What this trial is testing

Membrane Target Detection for Leukemia Treatment

Who this might be right for
Hematological Malignancy
University of Missouri-Columbia 50
Early research (Phase 1)Looking for participantsNCT06550713
What this trial is testing

A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 100
Early research (Phase 1)Ended earlyNCT06018506
What this trial is testing

A Phase I Study of BR108 in Hematological Malignancies

Who this might be right for
Hematologic Malignancy
BioRay Pharmaceutical Co., Ltd. 8
Testing effectiveness (Phase 2)Looking for participantsNCT06697184
What this trial is testing

Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

Who this might be right for
Chronic Lymphocytic LeukemiaCLLMantle Cell Lymphoma+1 more
BeOne Medicines 258
Early research (Phase 1)UnknownNCT04243434
What this trial is testing

PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients

Who this might be right for
Hematologic Diseases
Acrotech Biopharma Inc. 56
Not applicableStudy completedNCT05793073
What this trial is testing

AMS Intervention for Early Adaptation of Empirical Antibiotic Therapy in High-risk Neutropenic Patients

Who this might be right for
Neutropenia
Centre Hospitalier Universitaire de Nice 55
Large-scale testing (Phase 3)Looking for participantsNCT07047456
What this trial is testing

Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT

Who this might be right for
Acute Graft Versus Host Disease
Anhui Provincial Hospital 134
Not applicableUnknownNCT04878822
What this trial is testing

Immunogenicity of Covid-19 Vaccination for Patients With Hematological Malignancies

Who this might be right for
ImmunogenicityHematological MalignanciesCovid-19+1 more
Ospedale di Circolo - Fondazione Macchi 300
Not applicableActive Not RecruitingNCT04167683
What this trial is testing

Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant

Who this might be right for
Hematologic DiseasesChronic Myeloid LeukemiaAcute Myeloid Leukemia+5 more
Rigshospitalet, Denmark 144
Testing effectiveness (Phase 2)Ended earlyNCT03214666
What this trial is testing

GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies

Who this might be right for
High-risk Myelodysplastic SyndromesAcute Myelogenous LeukemiaSystemic Mastocytosis+1 more
GT Biopharma, Inc. 12
Testing effectiveness (Phase 2)Study completedNCT00796068
What this trial is testing

Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+4 more
Fred Hutchinson Cancer Center 130
Testing effectiveness (Phase 2)UnknownNCT04582604
What this trial is testing

Ruxolitinib and Decitabine for High Risk Hematological Malignancies

Who this might be right for
Peripheral Blood Stem Cell Transplantation
Chinese PLA General Hospital 60
Testing effectiveness (Phase 2)Study completedNCT04975555
What this trial is testing

Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy

Who this might be right for
Cytokine Release SyndromeICANSLymphoma, Non-Hodgkin+2 more
University of Alabama at Birmingham 20
Not applicableWithdrawnNCT03086252
What this trial is testing

Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study

Who this might be right for
AnemiaAplastic AnemiaBone Marrow Failure+3 more
Emory University
Testing effectiveness (Phase 2)Study completedNCT01162096
What this trial is testing

Reduced Intensity Haploidentical Transplant for Hematological Malignancies

Who this might be right for
Hematological Malignancies
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 34
Next Page